LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Health & Fitness
• Science
• Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

patients, anakinra, treatment, article, pubmed, disease, table, google, scholar, diseases, arthritis, antiil, syndrome, canakinumab, efficacy, duration, received, aes, study, clinical, reported, cas, response, data, children, sjia, tolerance, liver, risk, adult, patient, paediatric, weight, information, autoinflammatory, severe, adults, association, analysis, main, france, gain, rheum, offlabel, gout, complete, rare, adverse, aosd, caps,

Topics {✒️}

eu/docs/en_gb/document_library/epar_-_product_information/human/000363/wc500042310 eu/docs/en_gb/document_library/epar_-_product_information/human/001109/wc500031680 université lille nord-de-france kuemmerle-deschner jb retrospective cross-sectional design article download pdf real-life clinical practice multi-factorial autoinflammatory diseases auto-immune diseases treated il-1-mediated autoinflammatory diseases autoinflammatory muckle-wells syndrome article rossi-semerano il-1r inhibitor anakinra interleukin-1-receptor antagonist anakinra maladies auto-inflammatoires sequential placebo-controlled studies minor injection-site reactions national reference centre mild injection-site reaction mild injection-site reactions anti–il-1 treatments anakinra label anti-interleukin-1 treatments nlrp12-asociated periodic syndrome anti–il-1 treatment included label anti–il-1 agent anti–il-1 treatment duration linda rossi-semerano 3-year open-label follow long-term anakinra treatment il-36 receptor antagonist anti–il-1 treatment anakinra generalized pustular psoriasis interleukin-1-receptor antagonist interleukin-1 receptor antagonist privacy choices/manage cookies anti–il-1 treatment efficacy auto-inflammatory diseases isabelle koné-paut behrens em open access license made substantial contributions inflammatory biological markers anti–il-1 treatments full access european medicines agency label search search familial mediterranean fever anti–il-1 drugs mas successfully treated interleukin-1 mediated diseases

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
         description:Despite their limited licensed indications, anti–interleukin-1 (anti–IL-1) agents are often used in clinical practice for an increasing number of auto-inflammatory diseases. We conducted a national cross-sectional observational study from January 2011 to January 2013 to record the off-label use of such agents in France. We aimed to estimate the off-label use of anti–IL-1 treatments in France, assess their efficacy in rare diseases, and increase the reporting of their possible side effects. Physicians answered a questionnaire that covered patient and disease data, anti–IL-1 agent use, efficacy and adverse events. The study involved adult or paediatric patient who had received an anti–IL-1 agent after January 2005 in France. In total, 189 patients from 38 centres were included. The main diseases were adult-onset Still’s disease (AOSD) (35), gout (28), systemic juvenile idiopathic arthritis (27), cryopyrin-associated periodic syndrome (CAPS) (21), familial Mediterranean fever (14) and mevalonate kinase deficiency (12). The main off-label used agent was anakinra, used at least once for 185 patients, with canakinumab used for 25. Anakinra was effective in most patients (90%), with higher complete clinical response rates for Schnitzler’s syndrome, gout, CAPS and AOSD. Overall, 58% of patients showed at least one adverse event, mainly minor injection-site reactions. The main reported serious adverse event was severe infection. Injection-site reactions and liver toxicity were significantly more frequent in children than adults. The main non-cutaneous adverse event was liver toxicity, significantly associated with treatment duration. Weight gain was reported in about 10% of patients and was associated with treatment duration and CAPS. Canakinumab was rarely used and showed better cutaneous tolerance than anakinra but similar rates of non-cutaneous and severe adverse events. Anakinra was well tolerated and effective in most patients with various inflammatory diseases. The main adverse events were mild injection-site reactions, especially in children. The survey allowed for collecting limited information on the off-label use of canakinumab.
         datePublished:2015-02-15T00:00:00Z
         dateModified:2015-02-15T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13023-015-0228-7
         keywords:
            Auto-inflammatory diseases
            IL-1
            Anakinra
            Canakinumab
            Tolerance
            Off-label
            Medicine/Public Health
            general
            Pharmacology/Toxicology
            Human Genetics
         image:
         isPartOf:
            name:Orphanet Journal of Rare Diseases
            issn:
               1750-1172
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Linda Rossi-Semerano
               affiliation:
                     name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
                     address:
                        name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Bruno Fautrel
               affiliation:
                     name:Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique
                     address:
                        name:Department of Rheumatology, Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daniel Wendling
               affiliation:
                     name:University Teaching Hospital, CHRU Besançon, and University of Franche-Comté
                     address:
                        name:Department of Rheumatology, University Teaching Hospital, CHRU Besançon, and University of Franche-Comté, Besançon, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eric Hachulla
               affiliation:
                     name:Hôpital Claude Huriez, Université Lille Nord-de-France
                     address:
                        name:Centre de Référence des Maladies Autoimmunes et systémiques Rares, Service de Médecine Interne, Hôpital Claude Huriez, Université Lille Nord-de-France, Lille Cedex, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Caroline Galeotti
               affiliation:
                     name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
                     address:
                        name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luca Semerano
               affiliation:
                     name:INSERM UMR 1125, Paris 13 University
                     address:
                        name:Department of Rheumatology, Hôpital Avicenne, APHP, INSERM UMR 1125, Paris 13 University, Bobigny, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isabelle Touitou
               affiliation:
                     name:Hôpital A de Villeneuve, CHRU Montpellier
                     address:
                        name:Maladies Auto-inflammatoires, Laboratoire de Génétique, Hôpital A de Villeneuve, CHRU Montpellier, Montpellier, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isabelle Koné-Paut
               affiliation:
                     name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
                     address:
                        name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
      description:Despite their limited licensed indications, anti–interleukin-1 (anti–IL-1) agents are often used in clinical practice for an increasing number of auto-inflammatory diseases. We conducted a national cross-sectional observational study from January 2011 to January 2013 to record the off-label use of such agents in France. We aimed to estimate the off-label use of anti–IL-1 treatments in France, assess their efficacy in rare diseases, and increase the reporting of their possible side effects. Physicians answered a questionnaire that covered patient and disease data, anti–IL-1 agent use, efficacy and adverse events. The study involved adult or paediatric patient who had received an anti–IL-1 agent after January 2005 in France. In total, 189 patients from 38 centres were included. The main diseases were adult-onset Still’s disease (AOSD) (35), gout (28), systemic juvenile idiopathic arthritis (27), cryopyrin-associated periodic syndrome (CAPS) (21), familial Mediterranean fever (14) and mevalonate kinase deficiency (12). The main off-label used agent was anakinra, used at least once for 185 patients, with canakinumab used for 25. Anakinra was effective in most patients (90%), with higher complete clinical response rates for Schnitzler’s syndrome, gout, CAPS and AOSD. Overall, 58% of patients showed at least one adverse event, mainly minor injection-site reactions. The main reported serious adverse event was severe infection. Injection-site reactions and liver toxicity were significantly more frequent in children than adults. The main non-cutaneous adverse event was liver toxicity, significantly associated with treatment duration. Weight gain was reported in about 10% of patients and was associated with treatment duration and CAPS. Canakinumab was rarely used and showed better cutaneous tolerance than anakinra but similar rates of non-cutaneous and severe adverse events. Anakinra was well tolerated and effective in most patients with various inflammatory diseases. The main adverse events were mild injection-site reactions, especially in children. The survey allowed for collecting limited information on the off-label use of canakinumab.
      datePublished:2015-02-15T00:00:00Z
      dateModified:2015-02-15T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13023-015-0228-7
      keywords:
         Auto-inflammatory diseases
         IL-1
         Anakinra
         Canakinumab
         Tolerance
         Off-label
         Medicine/Public Health
         general
         Pharmacology/Toxicology
         Human Genetics
      image:
      isPartOf:
         name:Orphanet Journal of Rare Diseases
         issn:
            1750-1172
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Linda Rossi-Semerano
            affiliation:
                  name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
                  address:
                     name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Bruno Fautrel
            affiliation:
                  name:Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique
                  address:
                     name:Department of Rheumatology, Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daniel Wendling
            affiliation:
                  name:University Teaching Hospital, CHRU Besançon, and University of Franche-Comté
                  address:
                     name:Department of Rheumatology, University Teaching Hospital, CHRU Besançon, and University of Franche-Comté, Besançon, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eric Hachulla
            affiliation:
                  name:Hôpital Claude Huriez, Université Lille Nord-de-France
                  address:
                     name:Centre de Référence des Maladies Autoimmunes et systémiques Rares, Service de Médecine Interne, Hôpital Claude Huriez, Université Lille Nord-de-France, Lille Cedex, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Caroline Galeotti
            affiliation:
                  name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
                  address:
                     name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luca Semerano
            affiliation:
                  name:INSERM UMR 1125, Paris 13 University
                  address:
                     name:Department of Rheumatology, Hôpital Avicenne, APHP, INSERM UMR 1125, Paris 13 University, Bobigny, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isabelle Touitou
            affiliation:
                  name:Hôpital A de Villeneuve, CHRU Montpellier
                  address:
                     name:Maladies Auto-inflammatoires, Laboratoire de Génétique, Hôpital A de Villeneuve, CHRU Montpellier, Montpellier, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isabelle Koné-Paut
            affiliation:
                  name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
                  address:
                     name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Orphanet Journal of Rare Diseases
      issn:
         1750-1172
      volumeNumber:10
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
      address:
         name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
         type:PostalAddress
      name:Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique
      address:
         name:Department of Rheumatology, Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique, Paris, France
         type:PostalAddress
      name:University Teaching Hospital, CHRU Besançon, and University of Franche-Comté
      address:
         name:Department of Rheumatology, University Teaching Hospital, CHRU Besançon, and University of Franche-Comté, Besançon, France
         type:PostalAddress
      name:Hôpital Claude Huriez, Université Lille Nord-de-France
      address:
         name:Centre de Référence des Maladies Autoimmunes et systémiques Rares, Service de Médecine Interne, Hôpital Claude Huriez, Université Lille Nord-de-France, Lille Cedex, France
         type:PostalAddress
      name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
      address:
         name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
         type:PostalAddress
      name:INSERM UMR 1125, Paris 13 University
      address:
         name:Department of Rheumatology, Hôpital Avicenne, APHP, INSERM UMR 1125, Paris 13 University, Bobigny, France
         type:PostalAddress
      name:Hôpital A de Villeneuve, CHRU Montpellier
      address:
         name:Maladies Auto-inflammatoires, Laboratoire de Génétique, Hôpital A de Villeneuve, CHRU Montpellier, Montpellier, France
         type:PostalAddress
      name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
      address:
         name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Linda Rossi-Semerano
      affiliation:
            name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
            address:
               name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Bruno Fautrel
      affiliation:
            name:Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique
            address:
               name:Department of Rheumatology, Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique, Paris, France
               type:PostalAddress
            type:Organization
      name:Daniel Wendling
      affiliation:
            name:University Teaching Hospital, CHRU Besançon, and University of Franche-Comté
            address:
               name:Department of Rheumatology, University Teaching Hospital, CHRU Besançon, and University of Franche-Comté, Besançon, France
               type:PostalAddress
            type:Organization
      name:Eric Hachulla
      affiliation:
            name:Hôpital Claude Huriez, Université Lille Nord-de-France
            address:
               name:Centre de Référence des Maladies Autoimmunes et systémiques Rares, Service de Médecine Interne, Hôpital Claude Huriez, Université Lille Nord-de-France, Lille Cedex, France
               type:PostalAddress
            type:Organization
      name:Caroline Galeotti
      affiliation:
            name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
            address:
               name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
               type:PostalAddress
            type:Organization
      name:Luca Semerano
      affiliation:
            name:INSERM UMR 1125, Paris 13 University
            address:
               name:Department of Rheumatology, Hôpital Avicenne, APHP, INSERM UMR 1125, Paris 13 University, Bobigny, France
               type:PostalAddress
            type:Organization
      name:Isabelle Touitou
      affiliation:
            name:Hôpital A de Villeneuve, CHRU Montpellier
            address:
               name:Maladies Auto-inflammatoires, Laboratoire de Génétique, Hôpital A de Villeneuve, CHRU Montpellier, Montpellier, France
               type:PostalAddress
            type:Organization
      name:Isabelle Koné-Paut
      affiliation:
            name:Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud
            address:
               name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
      name:Department of Rheumatology, Hôpital La Pitié Salpêtrière, APHP; UPMC, GRC 08, Institut Pierre Louis d’Epidémiologie et Santé Publique, Paris, France
      name:Department of Rheumatology, University Teaching Hospital, CHRU Besançon, and University of Franche-Comté, Besançon, France
      name:Centre de Référence des Maladies Autoimmunes et systémiques Rares, Service de Médecine Interne, Hôpital Claude Huriez, Université Lille Nord-de-France, Lille Cedex, France
      name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France
      name:Department of Rheumatology, Hôpital Avicenne, APHP, INSERM UMR 1125, Paris 13 University, Bobigny, France
      name:Maladies Auto-inflammatoires, Laboratoire de Génétique, Hôpital A de Villeneuve, CHRU Montpellier, Montpellier, France
      name:Department of Paediatric Rheumatology, Hôpital de Bicêtre, APHP, National Reference Centre for Auto-inflammatory Diseases, Le Kremlin-Bicêtre, University of Paris Sud, Le Kremlin, France

External Links {🔗}(153)

• Revenue of https://www.springernature.com/gp/authors
• Monthly income for https://link.springernature.com/home/
• What's https://order.springer.com/public/cart's gross income?
• Financial intake of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• How much does https://ojrd.biomedcentral.com/about generate monthly?
• How much cash flow does https://www.editorialmanager.com/ojrd have monthly?
• How profitable is http://www.cri-net.com?
• Earnings of https://doi.org/10.1002%2Fart.30105
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20967858 gross monthly?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=The%20emerging%20role%20of%20interleukin-1beta%20in%20autoinflammatory%20diseases&journal=Arthritis%20Rheum&doi=10.1002%2Fart.30105&volume=63&pages=314-24&publication_year=2011&author=Lachmann%2CHJ&author=Quartier%2CP&author=So%2CA&author=Hawkins%2CPN?
• What are the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016572?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24131530 make?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20expanding%20spectrum%20of%20rare%20monogenic%20autoinflammatory%20diseases&journal=Orphanet%20J%20Rare%20Dis&doi=10.1186%2F1750-1172-8-162&volume=8&publication_year=2013&author=Touitou%2CI&author=Galeotti%2CC&author=Rossi-Semerano%2CL&author=Hentgen%2CV&author=Piram%2CM&author=Kone-Paut%2CI generate?
• How much does https://doi.org/10.3389%2Ffimmu.2013.00351 net monthly?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814084?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24198817 generate monthly?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=The%20Central%20Role%20of%20Anti-IL-1%20Blockade%20in%20the%20Treatment%20of%20Monogenic%20and%20Multi-Factorial%20Autoinflammatory%20Diseases&journal=Frontiers%20in%20immunology&doi=10.3389%2Ffimmu.2013.00351&volume=4&publication_year=2013&author=Federici%2CS&author=Martini%2CA&author=Gattorno%2CM?
• How much cash flow does https://doi.org/10.1002%2Facr.21901 have monthly?
• http://scholar.google.com/scholar_lookup?&title=Anakinra%20in%20adult-onset%20Still%27s%20disease%3A%20long-term%20treatment%20in%20patients%20resistant%20to%20conventional%20therapy&journal=Arthritis%20Care%20Res&doi=10.1002%2Facr.21901&volume=65&pages=822-6&publication_year=2013&author=Giampietro%2CC&author=Ridene%2CM&author=Lequerre%2CT&author=Costedoat%20Chalumeau%2CN&author=Amoura%2CZ&author=Sellam%2CJ's total income per month
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218906?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21682863 pull in monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20long-term%20follow-up%20of%20IL-1R%20inhibitor%20anakinra%20in%20adults%20with%20Still%27s%20disease%3A%20a%20case-series%20study&journal=Arthritis%20Res%20Ther&doi=10.1186%2Far3366&volume=13&publication_year=2011&author=Laskari%2CK&author=Tzioufas%2CAG&author=Moutsopoulos%2CHM bring in each month?
• What are the earnings of https://doi.org/10.3899%2Fjrheum.111549?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22859346's total income per month
• How much does http://scholar.google.com/scholar_lookup?&title=Beneficial%20effect%20of%20interleukin%201%20inhibition%20with%20anakinra%20in%20adult-onset%20Still%27s%20disease.%20An%20open%2C%20randomized%2C%20multicenter%20study&journal=J%20Rheumatol&doi=10.3899%2Fjrheum.111549&volume=39&pages=2008-11&publication_year=2012&author=Nordstrom%2CD&author=Knight%2CA&author=Luukkainen%2CR&author=Vollenhoven%2CR&author=Rantalaiho%2CV&author=Kajalainen%2CA pull in?
• See how much https://doi.org/10.1136%2Fard.2010.134254 makes per month
• What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070271?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21173013 generate monthly?
• Earnings of http://scholar.google.com/scholar_lookup?&title=A%20multicentre%2C%20randomised%2C%20double-blind%2C%20placebo-controlled%20trial%20with%20the%20interleukin-1%20receptor%20antagonist%20anakinra%20in%20patients%20with%20systemic-onset%20juvenile%20idiopathic%20arthritis%20%28ANAJIS%20trial%29&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2010.134254&volume=70&pages=747-54&publication_year=2011&author=Quartier%2CP&author=Allantaz%2CF&author=Cimaz%2CR&author=Pillet%2CP&author=Messiaen%2CC&author=Bardin%2CC
• What's the financial intake of https://doi.org/10.1056%2FNEJMoa1205099?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23252526?
• http://scholar.google.com/scholar_lookup?&title=Two%20randomized%20trials%20of%20canakinumab%20in%20systemic%20juvenile%20idiopathic%20arthritis&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1205099&volume=367&pages=2396-406&publication_year=2012&author=Ruperto%2CN&author=Brunner%2CHI&author=Quartier%2CP&author=Constantin%2CT&author=Wulffraat%2CN&author=Horneff%2CG's revenue stream
• What's the financial gain of https://doi.org/10.1056%2FNEJM200306193482523?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12815153 is on a monthly basis
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Interleukin-1-receptor%20antagonist%20in%20the%20Muckle-Wells%20syndrome&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200306193482523&volume=348&pages=2583-4&publication_year=2003&author=Hawkins%2CPN&author=Lachmann%2CHJ&author=McDermott%2CMF
• How much does https://doi.org/10.1056%2FNEJMoa055137 gross monthly?
• Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178954
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16899778?
• How much does http://scholar.google.com/scholar_lookup?&title=Neonatal-onset%20multisystem%20inflammatory%20disease%20responsive%20to%20interleukin-1beta%20inhibition&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa055137&volume=355&pages=581-92&publication_year=2006&author=Goldbach-Mansky%2CR&author=Dailey%2CNJ&author=Canna%2CSW&author=Gelabert%2CA&author=Jones%2CJ&author=Rubin%2CBI pull in monthly?
• Income figures for https://doi.org/10.1002%2Fart.23687
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18668535
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20rilonacept%20%28interleukin-1%20Trap%29%20in%20patients%20with%20cryopyrin-associated%20periodic%20syndromes%3A%20results%20from%20two%20sequential%20placebo-controlled%20studies&journal=Arthritis%20Rheum&doi=10.1002%2Fart.23687&volume=58&pages=2443-52&publication_year=2008&author=Hoffman%2CHM&author=Throne%2CML&author=Amar%2CNJ&author=Sebai%2CM&author=Kivitz%2CAJ&author=Kavanaugh%2CA is on a monthly basis
• How much money does https://doi.org/10.1056%2FNEJMoa0810787 make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19494217 pull in?
• How much does http://scholar.google.com/scholar_lookup?&title=Use%20of%20canakinumab%20in%20the%20cryopyrin-associated%20periodic%20syndrome&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0810787&volume=360&pages=2416-25&publication_year=2009&author=Lachmann%2CHJ&author=Kone-Paut%2CI&author=Kuemmerle-Deschner%2CJB&author=Leslie%2CKS&author=Hachulla%2CE&author=Quartier%2CP make?
• https://doi.org/10.1002%2Fart.34409's total income per month
• How much income is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474541 earning monthly?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22294344?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Sustained%20response%20and%20prevention%20of%20damage%20progression%20in%20patients%20with%20neonatal-onset%20multisystem%20inflammatory%20disease%20treated%20with%20anakinra%3A%20a%20cohort%20study%20to%20determine%20three-%20and%20five-year%20outcomes&journal=Arthritis%20Rheum&doi=10.1002%2Fart.34409&volume=64&pages=2375-86&publication_year=2012&author=Sibley%2CCH&author=Plass%2CN&author=Snow%2CJ&author=Wiggs%2CEA&author=Brewer%2CCC&author=King%2CKA?
• What are the total earnings of https://doi.org/10.1016%2Fj.semarthrit.2010.11.003?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21277619
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Interleukin-1%20targeting%20drugs%20in%20familial%20Mediterranean%20fever%3A%20a%20case%20series%20and%20a%20review%20of%20the%20literature&journal=Semin%20Arthritis%20Rheum&doi=10.1016%2Fj.semarthrit.2010.11.003&volume=41&pages=265-71&publication_year=2011&author=Meinzer%2CU&author=Quartier%2CP&author=Alexandra%2CJF&author=Hentgen%2CV&author=Retornaz%2CF&author=Kone-Paut%2CI
• What is the monthly revenue of https://doi.org/10.3899%2Fjrheum.100718?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21159830 is on a monthly basis
• How much income does http://scholar.google.com/scholar_lookup?&title=Anti-interleukin%201%20treatment%20for%20patients%20with%20familial%20Mediterranean%20fever%20resistant%20to%20colchicine&journal=J%20Rheumatol&doi=10.3899%2Fjrheum.100718&volume=38&pages=516-8&publication_year=2011&author=Ozen%2CS&author=Bilginer%2CY&author=Aktay%20Ayaz%2CN&author=Calguneri%2CM have?
• How much income is https://doi.org/10.1136%2Fannrheumdis-2011-201268 earning monthly?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22753383?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20autoinflammatory%20diseases%3A%20results%20from%20the%20Eurofever%20Registry%20and%20a%20literature%20review&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2011-201268&volume=72&pages=678-85&publication_year=2013&author=Haar%2CN&author=Lachmann%2CH&author=Ozen%2CS&author=Woo%2CP&author=Uziel%2CY&author=Modesto%2CC generate?
• How much does https://doi.org/10.1093%2Frheumatology%2Fkes097 pull in?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22740624?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20interleukin-1-targeting%20drugs%20in%20mevalonate%20kinase%20deficiency&journal=Rheumatology&doi=10.1093%2Frheumatology%2Fkes097&volume=51&pages=1855-9&publication_year=2012&author=Galeotti%2CC&author=Meinzer%2CU&author=Quartier%2CP&author=Rossi-Semerano%2CL&author=Bader-Meunier%2CB&author=Pillet%2CP have monthly?
• Profit of https://doi.org/10.1002%2Fart.23475
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18438813?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Persistent%20efficacy%20of%20anakinra%20in%20patients%20with%20tumor%20necrosis%20factor%20receptor-associated%20periodic%20syndrome&journal=Arthritis%20Rheum&doi=10.1002%2Fart.23475&volume=58&pages=1516-20&publication_year=2008&author=Gattorno%2CM&author=Pelagatti%2CMA&author=Meini%2CA&author=Obici%2CL&author=Barcellona%2CR&author=Federici%2CS?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20119842 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Dramatic%20response%20to%20IL1-RA%20treatment%20in%20longstanding%20multidrug%20resistant%20Schnitzler%27s%20syndrome%3A%20a%20case%20report%20and%20literature%20review&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-010-1375-9&volume=29&pages=567-71&publication_year=2010&author=Besada%2CE&author=Nossent%2CH pull in monthly?
• https://doi.org/10.1136%2Fard.2005.045245's total income per month
• How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798111 generate?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16096327?
• Get to know http://scholar.google.com/scholar_lookup?&title=Beneficial%20response%20to%20anakinra%20and%20thalidomide%20in%20Schnitzler%27s%20syndrome&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2005.045245&volume=65&pages=542-4&publication_year=2006&author=Koning%2CHD&author=Bodar%2CEJ&author=Simon%2CA&author=Hilst%2CJC&author=Netea%2CMG&author=Meer%2CJW's earnings
• How much does https://doi.org/10.3109%2F03009742.2010.493894 make?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20936987?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20Schnitzler%27s%20syndrome%20with%20anakinra%3A%20report%20of%20three%20cases%20and%20review%20of%20the%20literature&journal=Scand%20J%20Rheumatol&doi=10.3109%2F03009742.2010.493894&volume=40&pages=74-9&publication_year=2011&author=Gran%2CJT&author=Midtvedt%2CO&author=Haug%2CS&author=Aukrust%2CP
• What are the earnings of https://doi.org/10.7326%2F0003-4819-153-1-201007060-00030?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20621920
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Successful%20treatment%20of%20generalized%20pustular%20psoriasis%20with%20the%20interleukin-1-receptor%20antagonist%20Anakinra%3A%20lack%20of%20correlation%20with%20IL1RN%20mutations&journal=Ann%20Intern%20Med&doi=10.7326%2F0003-4819-153-1-201007060-00030&volume=153&pages=66-7&publication_year=2010&author=Viguier%2CM&author=Guigue%2CP&author=Pages%2CC&author=Smahi%2CA&author=Bachelez%2CH
• What's the monthly income of https://doi.org/10.1111%2Fbjd.12548?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23909475
• http://scholar.google.com/scholar_lookup?&title=Successful%20therapy%20with%20anakinra%20in%20a%20patient%20with%20generalized%20pustular%20psoriasis%20carrying%20IL36RN%20mutations&journal=Br%20J%20Dermatol&doi=10.1111%2Fbjd.12548&volume=170&pages=202-4&publication_year=2014&author=Huffmeier%2CU&author=Watzold%2CM&author=Mohr%2CJ&author=Schon%2CMP&author=Mossner%2CR's revenue stream
• Discover the revenue of https://doi.org/10.1542%2Fpeds.2012-3935
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24019411 have?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=First%20clinical%20description%20of%20an%20infant%20with%20interleukin-36-receptor%20antagonist%20deficiency%20successfully%20treated%20with%20anakinra&journal=Pediatrics&doi=10.1542%2Fpeds.2012-3935&volume=132&pages=e1043-7&publication_year=2013&author=Rossi-Semerano%2CL&author=Piram%2CM&author=Chiaverini%2CC&author=Ricaud%2CD&author=Smahi%2CA&author=Kone-Paut%2CI
• What's the profit of https://doi.org/10.1038%2Fnature04516?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16407889
• Income figures for http://scholar.google.com/scholar_lookup?&title=Gout-associated%20uric%20acid%20crystals%20activate%20the%20NALP3%20inflammasome&journal=Nature&doi=10.1038%2Fnature04516&volume=440&pages=237-41&publication_year=2006&author=Martinon%2CF&author=Petrilli%2CV&author=Mayor%2CA&author=Tardivel%2CA&author=Tschopp%2CJ
• How much does https://doi.org/10.1136%2Fannrheumdis-2011-200908 rake in every month?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22586173?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Canakinumab%20for%20acute%20gouty%20arthritis%20in%20patients%20with%20limited%20treatment%20options%3A%20results%20from%20two%20randomised%2C%20multicentre%2C%20active-controlled%2C%20double-blind%20trials%20and%20their%20initial%20extensions&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2011-200908&volume=71&pages=1839-48&publication_year=2012&author=Schlesinger%2CN&author=Alten%2CRE&author=Bardin%2CT&author=Schumacher%2CHR&author=Bloch%2CM&author=Gimona%2CA?
• Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978950
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24432362 earns monthly
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20anakinra%20in%20gouty%20arthritis%3A%20a%20retrospective%20study%20of%2040%20cases&journal=Arthritis%20Res%20Ther&doi=10.1186%2Far4303&volume=15&publication_year=2013&author=Ottaviani%2CS&author=Molto%2CA&author=Ea%2CHK&author=Neveu%2CS&author=Gill%2CG&author=Brunier%2CL?
• How much profit is https://doi.org/10.1002%2Facr.21989 making per month?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20acute%20gouty%20arthritis%20in%20complex%20hospitalized%20patients%20with%20anakinra&journal=Arthritis%20Care%20Res&doi=10.1002%2Facr.21989&volume=65&pages=1381-4&publication_year=2013&author=Ghosh%2CP&author=Cho%2CM&author=Rawat%2CG&author=Simkin%2CPA&author=Gardner%2CGC
• Profit of https://doi.org/10.1136%2Fard.2007.076034
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17947302?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Interleukin-1%20receptor%20antagonist%20%28anakinra%29%20treatment%20in%20patients%20with%20systemic-onset%20juvenile%20idiopathic%20arthritis%20or%20adult%20onset%20Still%20disease%3A%20preliminary%20experience%20in%20France&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2007.076034&volume=67&pages=302-8&publication_year=2008&author=Lequerre%2CT&author=Quartier%2CP&author=Rosellini%2CD&author=Alaoui%2CF&author=Bandt%2CM&author=Mejjad%2CO
• What's http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000363/WC500042310.pdf's gross income?
• What's the income of https://doi.org/10.1136%2Fard.2005.048371?
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798263's revenue stream
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16396977 earns monthly
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Safety%20of%20extended%20treatment%20with%20anakinra%20in%20patients%20with%20rheumatoid%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2005.048371&volume=65&pages=1006-12&publication_year=2006&author=Fleischmann%2CRM&author=Tesser%2CJ&author=Schiff%2CMH&author=Schechtman%2CJ&author=Burmester%2CGR&author=Bennett%2CR each month?
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17343315 have?
• How much does http://scholar.google.com/scholar_lookup?&title=Occult%20macrophage%20activation%20syndrome%20in%20patients%20with%20systemic%20juvenile%20idiopathic%20arthritis&journal=J%20Rheumatol&volume=34&pages=1133-8&publication_year=2007&author=Behrens%2CEM&author=Beukelman%2CT&author=Paessler%2CM&author=Cron%2CRQ pull in monthly?
• Monthly income for https://doi.org/10.1002%2Fart.22416
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17328073 generate?
• Profit of http://scholar.google.com/scholar_lookup?&title=The%20diagnostic%20significance%20of%20soluble%20CD163%20and%20soluble%20interleukin-2%20receptor%20alpha-chain%20in%20macrophage%20activation%20syndrome%20and%20untreated%20new-onset%20systemic%20juvenile%20idiopathic%20arthritis&journal=Arthritis%20Rheum&doi=10.1002%2Fart.22416&volume=56&pages=965-71&publication_year=2007&author=Bleesing%2CJ&author=Prada%2CA&author=Siegel%2CDM&author=Villanueva%2CJ&author=Olson%2CJ&author=Ilowite%2CNT
• See how much https://doi.org/10.1093%2Frheumatology%2Fkeq218 makes per month
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20693540
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Successful%20treatment%20of%20severe%20paediatric%20rheumatic%20disease-associated%20macrophage%20activation%20syndrome%20with%20interleukin-1%20inhibition%20following%20conventional%20immunosuppressive%20therapy%3A%20case%20series%20with%2012%20patients&journal=Rheumatology&doi=10.1093%2Frheumatology%2Fkeq218&volume=50&pages=417-9&publication_year=2011&author=Miettunen%2CPM&author=Narendran%2CA&author=Jayanthan%2CA&author=Behrens%2CEM&author=Cron%2CRQ produce monthly?
• What is the monthly revenue of https://doi.org/10.1002%2Fart.25057?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20039428
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Long-term%20efficacy%20of%20the%20interleukin-1%20receptor%20antagonist%20anakinra%20in%20ten%20patients%20with%20neonatal-onset%20multisystem%20inflammatory%20disease%2Fchronic%20infantile%20neurologic%2C%20cutaneous%2C%20articular%20syndrome&journal=Arthritis%20Rheum&doi=10.1002%2Fart.25057&volume=62&pages=258-67&publication_year=2010&author=Neven%2CB&author=Marvillet%2CI&author=Terrada%2CC&author=Ferster%2CA&author=Boddaert%2CN&author=Couloignier%2CV
• Revenue of https://doi.org/10.1002%2Fart.30149
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21360513?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20anakinra%20therapy%20in%20pediatric%20and%20adult%20patients%20with%20the%20autoinflammatory%20Muckle-Wells%20syndrome&journal=Arthritis%20Rheum&doi=10.1002%2Fart.30149&volume=63&pages=840-9&publication_year=2011&author=Kuemmerle-Deschner%2CJB&author=Tyrrell%2CPN&author=Koetter%2CI&author=Wittkowski%2CH&author=Bialkowski%2CA&author=Tzaribachev%2CN have monthly?
• Earnings of http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001109/WC500031680.pdf
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17418007 produce monthly?
• http://scholar.google.com/scholar_lookup?&title=Visceral%20leishmaniasis%20in%20a%20patient%20with%20systemic%20juvenile%20arthritis%20treated%20by%20IL-1RA%20agonist%20%28Anakinra%29&journal=Clin%20Exp%20Rheumatol&volume=25&publication_year=2007&author=Kone-Paut%2CI&author=Retornaz%2CK&author=Garnier%2CJM&author=Bader-Meunier%2CB's financial summary
• What's the financial intake of https://citation-needed.springer.com/v2/references/10.1186/s13023-015-0228-7?format=refman&flavour=references?
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Linda%20Rossi-Semerano
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Linda%20Rossi-Semerano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bruno%20Fautrel income
• What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bruno%20Fautrel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Daniel%20Wendling
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Daniel%20Wendling%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eric%20Hachulla?
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eric%20Hachulla%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Caroline%20Galeotti pull in monthly?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Caroline%20Galeotti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luca%20Semerano's total income per month
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luca%20Semerano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Isabelle%20Touitou rake in every month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Isabelle%20Touitou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Isabelle%20Kon%C3%A9-Paut
• What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Isabelle%20Kon%C3%A9-Paut%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://static-content.springer.com/esm/art%3A10.1186%2Fs13023-015-0228-7/MediaObjects/13023_2015_228_MOESM1_ESM.docx
• How much revenue does https://crossmark.crossref.org/dialog/?doi=10.1186/s13023-015-0228-7 generate?
• How much money does https://citation-needed.springer.com/v2/references/10.1186/s13023-015-0228-7?format=refman&flavour=citation generate?
• How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral bring in each month?
• Get to know https://www.springernature.com/gp/products's earnings
• What is the monthly revenue of https://www.springernature.com/gp/librarians?
• What's the financial gain of https://www.springernature.com/gp/societies?
• How much income is https://www.springernature.com/gp/partners earning monthly?
• How much does https://www.springer.com/ generate monthly?
• How much does https://www.nature.com/ pull in monthly?
• How profitable is https://www.biomedcentral.com/?
• Learn how profitable https://www.palgrave.com/ is on a monthly basis
• What are the total earnings of https://www.apress.com/?
• https://www.springernature.com/gp/legal/ccpa's total income per month
• What's the profit of https://www.springernature.com/gp/info/accessibility?
• How much income is https://support.springernature.com/en/support/home earning monthly?
• What's the income generated by https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations each month?
• How much does https://www.springernature.com/ make?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref